Time-Restricted Eating for Obesity
(SHIFT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how changing meal timing might aid weight loss, particularly for night shift nurses and nursing assistants. Participants will be divided into three groups: one will track their eating (Dietary Monitoring), another will follow a 10-hour eating window (Time-Restricted Eating, or TRE), and the last group will do the same but can have a low-sugar snack during night shifts (Time-Restricted Eating with a Low-Glycemic Snack, or TRE-LGS). The trial aims to determine if these methods improve health and weight over time. It seeks night shift nurses or nursing assistants who eat over a 14-hour period daily and have weight concerns. As an unphased trial, this study offers a unique opportunity to explore innovative eating strategies that could enhance health and well-being.
Do I have to stop taking my current medications for the trial?
The trial does not require you to stop taking your current medications, especially if you are on cardiovascular medications like statins, metformin, or anti-hypertensive drugs. However, if you are using medications known to cause weight loss or have had recent changes in medications that could impact study outcomes, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that time-restricted eating (TRE), where eating occurs only during certain hours each day, is generally safe for most people. Studies suggest that TRE can improve insulin levels and may support weight loss. One study found no major safety concerns when participants followed a 10-hour eating window.
For those trying TRE with a low-glycemic snack, research indicates it can aid weight loss and improve sugar processing in the body. These studies reported no significant safety issues, even over several months.
In summary, both TRE and TRE with a low-glycemic snack are well-tolerated and have shown no major side effects in previous research.12345Why are researchers excited about this trial?
Researchers are excited about time-restricted eating with a low-glycemic snack (TRE-LGS) for obesity because it introduces a novel approach to managing eating patterns. Unlike standard obesity treatments that often focus on calorie restriction or medication, TRE-LGS emphasizes eating within a specific 10-hour window, which can help regulate metabolism and potentially improve weight management. Additionally, the inclusion of a low-glycemic snack is designed to stabilize blood sugar levels, especially during night shifts, offering a tailored solution for those with irregular schedules. This method could make it easier for people to stick to healthier eating habits without drastically changing their calorie intake.
What evidence suggests that this trial's treatments could be effective for obesity?
Research has shown that time-restricted eating (TRE), one of the approaches studied in this trial, can aid in weight loss. Participants following TRE have lost 3% to 5% of their body weight over 2 to 12 months. This method also tends to improve blood pressure and mood. Another approach in this trial, Time-Restricted Eating with a Low-Glycemic Snack (TRE-LGS), includes a healthy snack that doesn't spike blood sugar. This addition can enhance TRE's effectiveness by helping the body manage sugar levels better. These findings suggest that adjusting eating times and incorporating a healthy snack might assist with weight control and overall health.23678
Who Is on the Research Team?
Emily Manoogian, Ph.D.
Principal Investigator
Salk Institute for Biological Studies
Are You a Good Fit for This Trial?
This trial is for nurses and nursing assistants who work night shifts, eat over a span of 14 hours or more daily, and are overweight. The study aims to see if changing when they eat can affect their health.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Guided Intervention
Participants undergo a 6-month guided intervention with dietary monitoring and time-restricted eating
Self-Guided Intervention
Participants continue with a 6-month self-guided intervention following the initial guided phase
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Dietary Monitoring
- Time-Restricted Eating (TRE)
- Time-Restricted Eating with a Low-Glycemic Snack (TRE-LGS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Salk Institute for Biological Studies
Lead Sponsor
University of San Diego
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator